David Hough

David Hough has over 40 years of work experience, starting with their tenure in the US Army as a Lieutenant Colonel. David then transitioned to roles in Johnson & Johnson Pharmaceutical Research and Development, where they served as Director and later Senior Director of CNS Research. Following this, they served as President of Psychiatric Services of Princeton. Hough then joined Janssen Research & Development LLC, where they held various leadership positions, including Vice President and Esketamine Compound Development Team Leader, as well as Schizophrenia Disease Area Leader in the Neuroscience Therapeutic Area. David was responsible for formulating and executing development strategies, managing clinical programs, and fostering partnerships. Hough also worked at PaxMedica as the Chief Medical Officer and later became the Chair of the Medical Advisory Board at Delica Therapeutics Pty. Ltd. Their most recent role is as the Chief Medical Officer at Freedom Biosciences. In addition to their employment, Hough has also worked as an Independent Consultant.

David Hough has a diverse educational background. David completed their Bachelor of Science (B.S.) degree in General Engineering at the United States Military Academy at West Point, although the specific years of their enrollment are unknown. David then pursued further education, earning a Doctor of Medicine (MD) degree from the Uniformed Services University between 1983 and 1987. Following this, they completed a Residency in Psychiatry at the Walter Reed National Military Medical Center from 1987 to 1991. Additionally, Hough attended the Walter Reed Army Institute of Research (WRAIR) from 1993 to 1995, where they obtained a Clinical Pharmacology Research Fellowship in the field of Clinical Pharmacology. However, no specific years are provided for their attendance at Upper Darby Senior High School.